Search research articles
Contact Us
Filters
Showing results (131-140 of 215) with videos related to
Page
of 22
Sort By:
Urology
|
November 1, 1978
Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test
G L Wright, P F Schellhammer, F E Rosato, et al.
British Journal of Urology
|
April 1, 1981
Primary mucinous adenocarcinoma of the renal pelvis
R M Wild, L E Ladaga, J S Copeland, et al.
Urology
|
October 1, 1986
Large renal masses in young adults
G H Jordan, D S Hartman, L E Ladaga, et al.
Urology
|
April 1, 1993
Reevaluation of prostate biopsy after definitive radiation therapy
E B Miller, L E Ladaga, A M el-Mahdi, et al.
Cancer
|
August 15, 1985
The effect of transurethral prostatic resection on the incidence of osseous prostatic metastasis
D A Kuban, A M el-Mahdi, P F Schellhammer, et al.
Urology
|
May 1, 1979
Transitional cell carcinoma: cause of refractory cancer of prostate
J R Wendelken, P F Schellhammer, L E Ladaga, et al.
Urology
|
March 4, 2000
Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy?
M F Sarosdy, P F Schellhammer, R Johnson, et al.
The Journal of Urology
|
October 1, 1985
Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancer
E L Robey, P F Schellhammer, G L Wright, et al.
The Urologic Clinics of North America
|
May 1, 1997
Prostate-specific antigen after radiation therapy. Prognosis by pretreatment level and post-treatment nadir
P F Schellhammer, A M el-Mahdi, D A Kuban, et al.
The Prostate
|
January 1, 1993
Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma
C L Huang, D Brassil, M Rozzell, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 215) with videos related to
Sort By:
Page
of 22
Urology
|
November 1, 1978
Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test
G L Wright, P F Schellhammer, F E Rosato, et al.
British Journal of Urology
|
April 1, 1981
Primary mucinous adenocarcinoma of the renal pelvis
R M Wild, L E Ladaga, J S Copeland, et al.
Urology
|
October 1, 1986
Large renal masses in young adults
G H Jordan, D S Hartman, L E Ladaga, et al.
Urology
|
April 1, 1993
Reevaluation of prostate biopsy after definitive radiation therapy
E B Miller, L E Ladaga, A M el-Mahdi, et al.
Cancer
|
August 15, 1985
The effect of transurethral prostatic resection on the incidence of osseous prostatic metastasis
D A Kuban, A M el-Mahdi, P F Schellhammer, et al.
Urology
|
May 1, 1979
Transitional cell carcinoma: cause of refractory cancer of prostate
J R Wendelken, P F Schellhammer, L E Ladaga, et al.
Urology
|
March 4, 2000
Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy?
M F Sarosdy, P F Schellhammer, R Johnson, et al.
The Journal of Urology
|
October 1, 1985
Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancer
E L Robey, P F Schellhammer, G L Wright, et al.
The Urologic Clinics of North America
|
May 1, 1997
Prostate-specific antigen after radiation therapy. Prognosis by pretreatment level and post-treatment nadir
P F Schellhammer, A M el-Mahdi, D A Kuban, et al.
The Prostate
|
January 1, 1993
Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma
C L Huang, D Brassil, M Rozzell, et al.
Page
of 22